Ashley Cordova, Chief Financial Officer at NovoCure Ltd (NVCR), sold 54,981 shares at $141.06 ($7.5M) on 2021-08-12, disclosed to the SEC on 2021-08-16.
Open-market sale of $7.5M NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,733 | $0 | 0.0% |
| 2 | $140.90 | 2,606 | $367K | 4.9% |
| 3 | $140.90 | 2,606 | $367K | 4.9% |
| 4 | $140.90 | 2,767 | $390K | 5.2% |
| 5 | $140.90 | 2,767 | $390K | 5.2% |
| 6 | $140.90 | 8,026 |
| $1.1M |
| 15.1% |
| 7 | $140.90 | 7,298 | $1.0M | 13.7% |
| 8 | $140.90 | 8,026 | $1.1M | 15.1% |
| 9 | $140.90 | 7,298 | $1.0M | 13.7% |
| 10 | $141.06 | 5,927 | $836K | 11.1% |
| 11 | $141.06 | 5,927 | $836K | 11.1% |
| Total | $136.49 avg | 54,981 | $7.5M | 100% |
| Filing → |
| NVCR | SELL | 2025-03-03 | $452K | — | Filing → |
| NVCR | SELL | 2024-08-05 | $14K | — | Filing → |
| NVCR | SELL | 2023-09-05 | $19K | — | Filing → |